Pfizer sells Capsugel to KKR; Ugene's al peptide drug delivery tech validated;

> Pfizer is selling its Capsugel drug-delivery business to KKR for $2.375 billion in cash, Pfizer announced Monday. Capsugel offers a variety of products, including liquid formulations as part of its Licaps Drug Delivery System. News

> Unigene Laboratories claims a Phase III trial has validated its oral peptide drug delivery technology. Item

> Amgen is looking for an executive director of drug delivery engineering in Thousand Oaks, CA. Job listing

> UK-based biotech companies Critical Pharmaceuticals and PolyTherics are collaborating on an injectable, sustained-release drug-delivery system. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.